Preview Mode Links will not work in preview mode

HR Benecast

Learn about new trends, developments, changes and other topics of interest in the employee benefits world from Employers Health’s Chief Strategy Officer, Mike Stull. During our monthly podcasts we’ll answer your most frequently asked human resources and employee benefits questions. 

  1. All Episodes
  2. Episode 48 - New and Noteworthy Biosimilars

Episode 48 - New and Noteworthy Biosimilars

Mar 27, 2025

Biosimilars have been around for nearly a decade, but with Humira's list price of around $7,000, biosimilars for the drug are making an incredible splash in the pharmacy industry. With several biosimilars already launched in 2025 and more in the pipeline, many plan sponsors are wondering how to navigate the integration of these products into their pharmacy benefit strategies.
 
In this episode, Employers Health's Mike Stull chats with Jeff Casberg, head of clinical pharmacy at IPD Analytics to discuss all things biosimilars, including how biosimilar launch dates and pricing are determined, cost savings associated with these products, the importance of biosimilar formulary positioning and more. 
 
Want to hear more from Jeff? Join us at the Annual Benefits Forum April 22-23 in Columbus, Ohio, where he'll present "The Impact of New Drugs and Therapies on PBM Spend."